Amexdrug logo

AXRX - Amexdrug Share Price

$0.054 0.0  0.0%

Last Trade - 27/07/20

Sector
Consumer Defensives
Size
Micro Cap
Market Cap £6.91m
Enterprise Value £7.32m
Revenue £6.97m
Position in Universe th / 6368
Bullish
Bearish
Unlock AXRX Revenue
Momentum
Relative Strength (%)
1m -16.8%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2007 2008 2009 2010 2011 2012 2013E 2014E CAGR / Avg
6.14 5.69 9.77 11.5 12.4 9.15 +8.3%
+83.3 -63.6 +37.5 +918.2 -45.5 -21.3
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the nine months ended 30 September 2013, Amexdrug Corporation revenues increased 2% to $6.8M. Net income increased from $182K to $385K. Revenues reflect Distribution segment increase of 73% to $2.9M, Health and Beauty Products segment increase from $376K to $1.5M. Net income benefited from Unrealized gain/ (loss)) increase of 39% to $1K (income).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

AXRX Revenue Unlock AXRX Revenue

Net Income

AXRX Net Income Unlock AXRX Revenue

Normalised EPS

AXRX Normalised EPS Unlock AXRX Revenue

PE Ratio Range

AXRX PE Ratio Range Unlock AXRX Revenue

Dividend Yield Range

AXRX Dividend Yield Range Unlock AXRX Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
AXRX EPS Forecasts Unlock AXRX Revenue
Profile Summary

Amexdrug Corporation, through its subsidiaries, is a pharmaceutical and cosmeceutical company. The Company specializes in the research and development, manufacturing and distribution of pharmaceutical drugs, cosmetics and distribution of prescription and over-the-counter (OTC) drugs, and private manufacturing and labeling. It operates through two segments: Distribution, and Health and Beauty Products. The Distribution segment consists of the wholesale pharmaceutical distribution and resale of brand and generic pharmaceutical products, OTC drugs and non-drug products, and health and beauty products. The Health and Beauty Products segment consists of the manufacture and distribution of primarily health and beauty products. It distributes products to independent pharmacies, small-sized pharmacy chains, alternative care facilities, and other wholesalers and retailers. Its subsidiaries include BioRx Pharmaceuticals, Inc., Allied Med, Inc., Dermagen, Inc. and Royal Health Care Company.

Directors
Last Annual December 31st, 2012
Last Interim September 30th, 2013
Incorporated December 4, 2001
Public Since July 21, 1972
No. of Shareholders: 192
No. of Employees: 9
Sector Consumer Defensives
Industry Food & Drug Retailing
Index
Exchange OTC Markets Group
Shares in Issue 169,409,620
Free Float (0.0%)
Eligible for
ISAs
SIPPs
AXRX Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for AXRX
Upcoming Events for AXRX
Frequently Asked Questions for Amexdrug
What is the Amexdrug share price?

As of 27/07/20, shares in Amexdrug are trading at $0.054, giving the company a market capitalisation of £6.91m. This share price information is delayed by 15 minutes.

How has the Amexdrug share price performed this year?

Shares in Amexdrug are currently trading at $0.054 and the price has moved by -55.79% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Amexdrug price has moved by -59.77% over the past year.

What are the analyst and broker recommendations for Amexdrug?

There are no analysts currently covering Amexdrug.

When will Amexdrug next release its financial results?

Amexdrug is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2014-09-30
What is the Amexdrug dividend yield?

Amexdrug does not currently pay a dividend.

Does Amexdrug pay a dividend?

Amexdrug does not currently pay a dividend.

When does Amexdrug next pay dividends?

Amexdrug does not currently pay a dividend.

How do I buy Amexdrug shares?

To buy shares in Amexdrug you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Amexdrug?

Shares in Amexdrug are currently trading at $0.054, giving the company a market capitalisation of £6.91m.

Where are Amexdrug shares listed? Where are Amexdrug shares listed?

Here are the trading details for Amexdrug:

Country of listing: United States
Exchange: OTC
Ticker Symbol: AXRX
What kind of share is Amexdrug?

We were not able to load our ranking data for Amexdrug

Is there a Amexdrug share price forecast 2020?

We were not able to load any forecast data for Amexdrug.

How can I tell whether the Amexdrug share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Amexdrug. Over the past six months, the relative strength of its shares against the market has been 6.68%. At the current price of $0.054, shares in Amexdrug are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Amexdrug PE Ratio?

The Amexdrug PE ratio based on its reported earnings over the past 12 months is 16.26. The shares are currently trading at $0.054.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Amexdrug?

Amexdrug's management team is headed by:

Rodney Barron - IND
Behrooz Meimand - IND
Jack Amin - PRE
Who are the major shareholders of Amexdrug?

Here are the top five shareholders of Amexdrug based on the size of their shareholding:

Similar to AXRX
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.